SEC Form 4 · accession 0001171843-15-001356
IMMUNOMEDICS INC · IMMU
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Peter P. Pfreundschuh
Officer — Chief Financial Officer
Period of report
Mar 9, 2015
Accepted (ET)
Mar 11, 2015 · 4:35 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000722830
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Options (right to buy)F1 | $4.01 | Mar 9, 2015 | A | 50,000 | A | — | Mar 9, 2022 | Common Stock, par value $0.01 per share | 50,000 | — | D |
Explanation of responses
- F1The reporting person was granted stock options pursuant to the Company's 2014 Long Term Incentive Plan. The stock options vest 25% on the first anniversary of the date of grant and 6.25% on a quarterly basis thereafter.